3.8 Article

CT perfusion for response evaluation after interventional ablation of hepatocellular carcinoma: a prospective study

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Hepatocellular carcinoma

Josep M. Llovet et al.

Summary: Liver cancer, particularly hepatocellular carcinoma (HCC), poses a significant global health challenge with rising incidence projected to exceed 1 million cases by 2025. Infection by hepatitis B and C viruses remains a major risk factor for HCC, while non-alcoholic steatohepatitis is emerging as a more common risk factor in Western countries. Advances in systemic therapies for HCC, including immunotherapies and targeted therapies, are expected to revolutionize the management of this disease.

NATURE REVIEWS DISEASE PRIMERS (2021)

Review Oncology

Hepatitis B-related hepatocellular carcinoma: surveillance strategy directed by immune-epidemiology

Chimaobi M. Anugwom et al.

Summary: Hepatitis B infection is a common cause of hepatocellular carcinoma worldwide, with varying age of onset, prognosis, and incidence depending on the region. Geographic variation is largely influenced by factors such as HBV incidence, age of virus transmission, integration timing into the human genome, and different HBV genotypes.

HEPATOMA RESEARCH (2021)

Review Oncology

Updates on Imaging of Liver Tumors

Arya Haj-Mirzaian et al.

CURRENT ONCOLOGY REPORTS (2020)

Review Oncology

Hepatocellular Carcinoma (HCC) in Egypt: A comprehensive overview

Wafaa M. Rashed et al.

JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE (2020)

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Peter R. Galle et al.

JOURNAL OF HEPATOLOGY (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

CT perfusion in hepatocellular carcinoma: Is it reliable?

Mennatallah Hatem Shalaby et al.

EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE (2017)

Article Radiology, Nuclear Medicine & Medical Imaging

Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients

Davide Ippolito et al.

EUROPEAN JOURNAL OF RADIOLOGY (2014)

Article Radiology, Nuclear Medicine & Medical Imaging

Computed Tomographic Perfusion Imaging for the Prediction of Response and Survival to Transarterial Radioembolization of Liver Metastases

Fabian Morsbach et al.

INVESTIGATIVE RADIOLOGY (2013)

Article Radiology, Nuclear Medicine & Medical Imaging

Hepatocellular Carcinoma: Assessment of Response to Transarterial Chemoembolization With Image Subtraction

Sooah Kim et al.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2010)

Review Gastroenterology & Hepatology

Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma

Riccardo Lencioni et al.

SEMINARS IN LIVER DISEASE (2010)

Article Gastroenterology & Hepatology

Assessment of the hepatic microvascular changes in liver cirrhosis by perfusion computed tomography

Mai-Lin Chen et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2009)

Article Radiology, Nuclear Medicine & Medical Imaging

The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma

IR Kamel et al.

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2006)